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Abstract
hTTLL12 is a member of the tubulin tyrosine ligase (TTL) family that is highly conserved in phylogeny. It has both SET-like
and TTL-like domains, suggesting that it could have histone methylation and tubulin tyrosine ligase activities. Altered
expression of hTTLL12 in human cells leads to specific changes in H4K20 trimethylation, and tubulin detyrosination,
hTTLL12 does not catalyse histone methylation or tubulin tyrosination in vitro, as might be expected from the lack of critical
amino acids in its SET-like and TTLL-like domains. hTTLL12 misexpression increases mitotic duration and chromosome
numbers. These results suggest that hTTLL12 has non-catalytic functions related to tubulin and histone modification, which
could be linked to its effects on mitosis and chromosome number stability.
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Introduction
The human genome codes for may proteins that have not been
assigned a validated function. In our screens of RNAs that are
differentially expressed in tumours, we identified a number of
encoded proteins with unknown functions that could potentially be
targeted for therapeutic intervention [1]. We selected hTTLL12
for further study, since it has enzymic features. We showed that
hTTLL12 is expressed in the proliferating layer of benign human
prostate, and expression increases during cancer progression to
metastasis. Overexpression alters chromosomal ploidy. These
results raise the possibility that hTTLL12 could contribute to
tumorigenesis through effects on chromosome number stability
[2]. In order to study whether hTTLL12 may have enzymatic
activity, we used sequence homology searches to reveal the
presence of SET-like and TTL-like domains in the N- and C-
terminal parts of the molecule, respectively.
SET domains are approximately 130 amino acids long and have
been found in all eukaryotic organisms studied so far. Their
principle function is to transfer a methyl group from S-adenosyl-L-
methionine (SAM) to the e-amino group of lysine residues on
histones or other proteins. Various histone lysine residues are
methylated, and the combination of these methylations and other
covalent modifications constitutes ‘‘the histone code’’ that has
epigenetic functions and regulates various cellular processes, such
as transcription and the organization of chromatin. Chromatin
condensation and compaction are essential for rapid chromosome
congression and accurate chromosome segregation during cell
division [reviews: [3,4,5,6,7]].
TTL domains are approximately 350 amino acid modules that
catalyze ligation of amino acids to tubulins or other substrates.
The TTL domain contains ATP-grasp-like motifs that correspond
to the ATP/Mg2+ binding site typical of enzymes with ATP-
dependent carboxylate-amine/thiol ligase activity [8]. This
domain is present in a family of proteins that has 14 members
in mouse. They have been shown to ligate tyrosine (TTL),
glutamate (TTLL1, 4, 5, 6, 7, 9, 11 and 13) or glycine (TTLL3, 8
and 10) to the C-terminal tails of a/b tubulin. TTL re-adds
tyrosine to a-tubulin that has been terminally detyrosinated, in a
process called the TTL cycle. TTLL1, 4, 5 and 7 ligate an initial
glutamate to a glutamic acid side chain through iso-peptide bonds,
whereas TTLL 6, 7, 9, 11 and 13 elongate polyglutamate chains
through peptide bonds. In related reactions, TTLL3 and 8 ligate
glycine to a glutamic acid side chain, whereas TTLL3 and 10
elongate polyglycine chains. Tubulin C-terminal tails are hotspots
for complex patterns of modifications, with important roles in
cellular processes that include subcellular organization, intra-
cellular transport, cell movement and mitosis [reviews:
[9,10,11,12,13]]. The complexity and importance of tubulin
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modifications has led to the analogy being made between the
‘‘tubulin code’’ and the better established ‘‘histone code’’ [14,15].
hTTLL12 is the least characterized and most unusual member
of the TTL family. We report its effects on histone and tubulin
modifications, mitotic duration and chromosome numbers.
hTTLL12 does not appear to have detectable in-vitro enzymatic
activity related to the changes observed in cells. We raise the
possibility that hTTLL12 is an inactive pseudo-enzyme that has
important regulatory roles, similar to pseudo-enzymes in other
protein families.
Materials and Methods
Materials
Details for vector constructs, siRNAs, antibody generation,
commercial antibodies and their dilutions used for western blotting
(WB) and immunocytochemistry, are described in Supporting
Information.
Databases searches
The initial step was an iterated PSI-BLAST search with the full-
length human hTTLL12 CDS against the nr database of NCBI
until convergence occurred. Similar PSI-BLAST searches were
performed using the C-terminal TTL-like domain and the N-
terminal unknown region [16].
Multiple sequence alignments and phylogenetic trees
For each domain or region, the detected homologs were
included in a clustered multiple alignment of complete sequences
(MACS) constructed using the PipeAlign program suite [17] and
subsequently manually adjusted. For the MACS of the N-terminal
of hTTLL12, SET domain containing proteins were retrieved
from PFAM (PF00856). Human SET domain proteins were
retained and aligned with the hTTLL12 sequence through
ClustalX and manually adjusted. The MACS of the TTL domain
was made using representative sequences for each human TTL-
like and TTL protein. All MACSs and details about the proteins
included are available in data. The PhyloWin program [18] was
used to generate the phylogenetic tree based on 212 positions of
the TTL domain MACS and using the neighbour-joining
reconstruction algorithm with pair-wise gap removal option and
1000 bootstrap replicates. The trees were edited and displayed
with TreeView [19].
Cell culture, transfection and generation of stable clones
HEp-2 cells (ATCC CCL-23) were grown in modified Eagle’s
medium (MEM), 10% foetal calf serum, 0.1 mM nonessential
amino acids, 1 mM Na-pyruvate, 40 mg/ml gentamicin at 37uC in
a humidified 5% CO2 atmosphere. siRNA transfections were
performed using Lipofectamine (Invitrogen) according to the
manufacturer’s protocol. In brief, 100,000 cells per well were
seeded in a 12 well plate, grown for 18 hours followed by 3 hours
OPTIMEM incubation and transfection during 6 hours. After
transfection, medium was changed to normal growth medium and
incubated as indicated until cell lysis. To obtain stable clones,
HEp-2 cells were transfected with the Flag-hTTLL12 expression
plasmid, the empty pSG5-puro-Flag plasmid [20] or the
ashTTLL12 expression plasmid using the BBS calcium phosphate
method [21]. 48 hours post-transfection, cells were passaged into
selection medium containing 3 mg/ml puromycin, renewed every
three days. 10–14 days post-transfection, we characterized five
positive clones per stable transfection by immunofluorescence and
WB giving rise to hTTLL12 clones A-E and Control clones A–E.
Since we did not observe significant difference between
ashTTLL12 clones and empty vector clones by various criteria
we considered the ashTTLL12 clones as additional negative
controls (Control clones F–G).
SDS-PAGE and WB
Standard procedures were used (see Supporting Experimental
Procedures S1 for details).
Co-immunoprecipitation
Nuclear extracts from hTTLL12_A, _B and _C clones were
prepared using the Nuclear Complex Co-IP Kit (Active Motif)
according to the manufacturer’s instructions. For tubulin co-
immunoprecipitation, 75% confluent hTTLL12 or control clones
were washed thrice with cold 16 PBS, lysed in RIPA buffer
(30 minutes, ice), scraped and cleared (12,000 g, 2 minutes). After
protein quantification of the supernatants (Bradford assay,
BioRad), 1 mg of proteins was pre-cleared with 100 ml of protein
A-Sepharose (Sigma-Aldrich, 30 minutes, 4uC). After centrifuga-
tion, supernatants were mixed to 100 ml of M2-sepharose (Sigma-
Aldrich) and incubated for 90 minutes at 4uC. Beads were washed
thrice, bound proteins were eluted by boiling in 100 ml 26 SDS
sample buffer (10 minutes) and centrifuged (10,000 g, 30 seconds).
The resulting supernatants were fractionated on a 8.5% SDS-
PAGE gel and WB was performed as described above.
Immunocytochemistry and Confocal Microscopy
Standard procedures were used (see Supporting Experimental
Procedures S1 for details).
Cell cycle synchronisation by double thymidine block
Cells were plated on 10 cm dishes in an amount (<750,000)
that would give 80% confluence in 4–5 days. After about 24 h
after plating, medium with 0.2 mM thymidine was applied for
23 h, then changed for fresh medium for 9 h, and again with
thymidine for 23 h. Cells were collected at 2 h time intervals for
18–24 h for FACS analysis for DNA content. Time points in
which cells were predominantly in the S1, G2/M and G1 phase
were selected for WBs.
Time-lapse microscopy
Control clones, hTTLL12 clones or parental HEp-2 cells were
seeded at a density of 200,000 cells/2 ml in six well cell culture
plates. siRNA transfection of parental HEp-2 cells was performed
as described above. 48 hours after seeding of the stable clones, or
72 hours after siRNA transfection [3 non-targeting control
siRNAs (siScramble, siLuciferase and siCtrl), or one of 6
hTTLL12-sepecific siRNAs (sihTTLL12_1-6)], cell cultures were
stained with vital Hoechst (3.3 mg/ml, Hoechst 33258, Molecular
Probes) during 30 minutes at 37uC and grown on a video
microscopy platform in a humidified 5% CO2 atmosphere. Images
were acquired in phase contrast and UV at 1 minute intervals
during 4 hours (Control and hTTLL12 clones) or 3 minutes
intervals during 10 hours (siRNA transfected cells) using a CCD
camera with a 406//0.55 N-Plan objective in an inverted
motorized microscope (DMIRE2, Leica). Analyses were per-
formed using ImageJ software (http://rsb.info.nih.gov/ij/). Mi-
totic duration was scored from cells that had one, normal-sized,
nucleus. The following numbers of cells were used to analyse: (a)
mitotic duration, 205 (HEp-2), 263 (Control clones), 372
(hTTLL12 clones), 591 (siControl transfected Hep-2), and 899
(sihTTLL12 transfected Hep-2); (b) spindle positioning, 262 (HEp-
2), 420 (Control clones), 380 (hTTLL12 clones), 502 (siControl
transfected Hep-2), and 973 (sihTTLL12 transfected Hep-2); (c)
hTTLL12: Histones, Tubulin and Mitosis
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congression delay, 420 (Control clones), 491 (hTTLL12 clones),
502 (siControl transfected Hep-2), and 852 (sihTTLL12 transfect-
ed Hep-2).
Cell growth
3,000 cells of hTTLL12 and Control clones (hTTLL12_A-E
and Control_A-E) were seeded per well of a 96 well plate. Cell
proliferation was assayed using the MTT-based colorimetric assay
(Chemicon Int.) following the manufacturer’s instructions.
Cell cycle analysis
Unsynchronized exponentially growing cells were fixed in 70%
ethanol (220uC), washed and stained with propidium iodide.
Detached cell populations were collected and combined with
adherent cells for all experiments. FACScalibur cytometer (Becton
Dickinson) and Cellquest software were used for acquisition, and
Modifit software (Verity) for cell cycle analysis.
In-vitro assays for histone methyl transferase and tubulin
tyrosine ligase and purification of proteins
Standard procedures were used as detailed in the Experimental
Procedures.
Statistics
Statistical analyses were carried out by Student’s t-test.
Results
Domain structure and phylogenetic distribution of
hTTLL12
We initially characterised human hTTLL12 using bioinfor-
matics. There are thirteen human proteins with homology to the
hTTLL12 C-terminal TTL domain (Figure 1A, Alignment S1)
[22,23]. The phylogenetic tree, based on the sequences of the TTL
domains (Figure 1B), has a relatively long branch for hTTLL12
compared to the other hTTL-like proteins, indicating that it is one
of the most divergent. The core TTL domain (416–642) of
hTTLL12 has a N-terminal extension (353–415) with weak
homology to the extended domains of the other hTTL family
members (Alignment S1 and data not shown). Despite the overall
similarity, the TTL domain of hTTLL12 has distinct features. It
lacks 2 of the six sequences predicted to bind ATP and Mg2+ in the
other TTL domains (Figure 1A, grey lines). It also lacks three of
the seven conserved motifs found in the other TTL family
members (Table S1). In addition, it contains specific residues that
are conserved in TTLL12s from other species (Table S1).
Interestingly, TTLL12 is widely conserved; it is found in simple
eukaryotes (Entamoeba, Trypanosomes, Paramecium, Tetrahy-
mena, Hydra), plants [monocots (Oryza sativa, Indian rice), eudicots
(Arabidopsis thaliana)], nematodes (Caenorhabditis elegans, etc.), flies
(Drosophila melanogaster, etc.) and higher eukaryotes (data not
shown). The conserved sequences include the N-terminal region,
which has a SET-like domain according to PSI-BLAST [16]
(amino acids 91 to 249 of hTTLL12; Figure 1A). This sequence
aligns with human SET domain proteins from PFAM (Alignment
S2), and is most related to the SET domains of SETD3, SETD4
and SETD6 (Figure 1C). Some of its sequences are highly
conserved in other human SET domains (see Table S2; letters
colours indicate degrees of conservation; red: absolutely conserved;
blue: very highly conserved; black: highly conserved). The highly
conserved sequences correspond to SET domain structural
elements, including b-strands, an a-helix and a linker region [6].
The hTTLL12 SET-like domain appears to contain an insert, as
found in iSET domains [24]. This insert lies between amino acids
158–188 (Alignment S2). Several plant and protozoan orthologues
have an additional sequence inserted in a position equivalent to
160 of hTTLL12, indicating that these orthologues have an iSET
domain with a large insert. In summary, hTTLL12 appears to be
an atypical member of the TTL protein family, from the presence
of a SET-like domain, the loss of conserved residues found in other
TTL family proteins, and the conservation of hTTLL12-specific
features throughout many species.
hTTLL12 selectively affects trimethylation of histone
H4K20 in cells
Since SET domain proteins methylate histone lysines [reviewed
in [25]], we studied whether hTTLL12 affects methylation of
histones H3 and H4. We generated stable clones of HEp-2 that
overexpress Flag-hTTLL12 (hTTLL12_A-E), and control clones
with the corresponding empty Flag-expression vector (Control_A-
E). Western blots (WBs) of total cell extracts were probed with
antibodies against hTTLL12, specific methylated forms of
H4K20, H3K9, H3K4 and H3K27, and a loading control
(TBP); suitably exposed films were quantitated (Figure 2A, see
lanes 1–6 for representative blots and the histogram for
quantification). hTTLL12 overexpression increased the levels of
H4K20 trimethylation (p = 0.005), without affecting total H4
protein levels (data not shown), or any of the other modifications
investigated. We then studied knockdown of hTTLL12 with
siRNAs. Decreasing hTTLL12 levels decreased H4K20me3 levels
(p = 0.029; Figure 2B; a representative WB is shown; the histogram
combines the results from four sihTTLL12 and four control
siRNAs in replicated experiments), whereas H3K9me3 levels were
not changed. These results show that up and down regulation of
hTTLL12 have opposing effects on H4K20 trimethylation. In
order to investigate whether there is a direct connection between
hTTLL12 and chromatin, we tested whether hTTLL12 interacts
with histones and chromatin components such as HP1 isoforms
[26,27]. We found that immunoprecipitates of Flag-hTTLL12
from nuclear extracts of hTTLL12 overexpressing clones con-
tained HP1c the nucleosomal component histone H3 and
H4K20me3 (Figure 2C). These proteins were not detected in
the controls, in which Flag-hTTLL12 pull down was inhibited
with the Flag peptide, indicating that the interactions were specific.
These results show that hTTLL12 interacts with chromatin
components.
hTTLL12 affects the levels of detyrosinated tubulin
hTTLL12 has a TTL-like domain, suggesting that it might
affect tubulin tyrosination. We measured the effects of increasing
and decreasing hTTLL12 levels in HEp-2 on detyrosinated
tubulin levels by WB with a specific antibody. hTTLL12
overexpression in the stable clones resulted in a significant nearly
two-fold increase in detyrosinated tubulin levels, compared to the
control clones (p = 0.003; Figure 3A, see the representative WB
and the combined data from 4 overexpression and 5 control
clones). Knockdown of endogenous hTTLL12 in HEp-2 cells also
resulted in a significant increase in detyrosinated tubulin levels
(p = 8.8 1025; Figure 3B; a representative WB is shown; the
histogram combines the results from six sihTTLL12 and four
control siRNAs in replicated experiments). As expected, TTL
knockdown also increased detyrosinated tubulin levels, but to a
greater extent than knockdown of hTTLL12, even though the
extents of knockdown were similar (80% or more, 2 siTTLs and 6
sihTTLL12s; data not shown). We were not able to detect
corresponding changes in tyrosinated tubulin, most likely due to
the technical limitations of WB and dot-blots. These techniques
hTTLL12: Histones, Tubulin and Mitosis
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did not accurately detect the small proportional changes that we
would expect to find (about 10%). Hep-2 express a high
proportion of tyrosinated tubulin relatively to detyrosinated
tubulin (data not shown), which reduces the proportional change
of tyrosinated tubulin that would result from conversion to
detyrosinated tubulin. Nevertheless, we did find that changes in
hTTLL12 levels increase tubulin detyrosination.
The effects of hTTLL12 on tubulin modification may result
from interactions with a-tubulin and tubulin-associated structures
in the cell. To detect interacting proteins, we immuno-purified
Flag-hTTLL12 from overexpressing clones with anti-Flag affinity
columns. Proteins that co-purified with Flag-hTTLL12 from
overexpressing clones were dissociated by boiling in loading buffer
and analysed by WB. a-tubulin was detected in extracts prepared
from the Flag-hTTLL12 overexpressing clones (Figure 3C, lane 3,
and data not shown), but not from cells that overexpress Flag-
NudCD2 (a different protein, lane 2) or from parental cells (lane
1). We also analysed proteins eluted with the FLAG peptide by
SDS-PAGE electrophoresis, silver staining and mass spectrometry.
One of the bands, that migrated around 50 kDa (the size of a-
tubulin) and that was not present in the sample purified from a
control clone, was shown to be a-tubulin by mass spectrometry
(Figure S1 and Table S3). These results suggest that hTTLL12
interacts specifically with a-tubulin.
We have previously reported that hTTLL12 co-localises with
the mitotic spindle during mitosis [2]. We verified that hTTLL12
has a similar location in HEp-2 cells. Cells were fixed,
permeabilised and stained with antibodies against hTTLL12 and
fluorescently labelled secondary antibodies, and observed by
confocal microscopy. The staining was specific, since knockdown
with different sihTTLL12s strongly decreased staining intensity
(data not shown). hTTLL12 (red; Figure S2) localised to dots on
mitotic spindle MTs that co-stained with a-tubulin antibodies
(green, Figure S2A). hTTLL12 also appeared to localize to
centrosomes, which were co-stained with beta/gamma-tubulin
(green; Figure S2B & C). These results indicate that hTTLL12
localises to the tubulin-rich mitotic spindle, which is consistent
with its ability to affect tubulin C-terminal modification.
H4K20me3 and tubulin detyrosination levels are altered
by TTLL2 expression at defined stages of the cell cycle
H4K20 methylation and tubulin tyrosination levels change
during the cell cycle [28,29]. hTTLL12 can affect cell cycle
distribution in some cell lines [2], suggesting that hTTLL12’s
effects on histone and tubulin modifications in HEp-2 could be an
indirect consequence of changes in cell cycle distribution. We
checked whether hTTLL12 expression affects cell cycle progres-
sion of HEp-2 cells. Using the MTT assay, we found that
hTTLL12 clones grew significantly more slowly from day 6
onwards (Figure S3A). Using WBs of cell extracts, we found that
the hTTLL12 clones expressed increased levels of Rb (p= 0.1
1023) and decreased levels of HP1a (p = 0.4 1024), without
changes in HP1b and HP1c (Figure S3B), as expected for
inhibition of cell cycle progression by hTTLL12 [30,31]. FACS
analysis showed that hTTLL12 clones also had a larger proportion
of cells in G2/M with tetraploid chromosome content (4c; Figure
Figure 1. hTTLL12, domain organisation and similarity with other proteins. A. Schematic representation. Red indicates the SET-like domain
(amino acids 91–249), blue the TTL-like domain (amino acids 353–642), yellow or grey the predicted ATP and Mg2+ binding amino acid motifs that are
respectively conserved (WICK416–419, SKYI450–453, DIRY470–473, EVN605–607), or non-conserved (SLDT426–429 and RAMYAVD578–584) in hTTLL12. B, C.
Phylogenetic trees of the TTL domains of the human TTL family based on Alignment S1 (B) and the SET-like domain of hTTLL12 and human SET
domains based on Alignment S2 (C). Bootstrap values are provided for significant nodes when they are .80%. Multiple sequence alignments are
available as data.
doi:10.1371/journal.pone.0051258.g001
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S3C). As observed previously [2], there were also cells with a
greater DNA content (8c), as expected from increased chromo-
some numbers. To measure this increase, we counted chromo-
somes in metaphase spreads of HEp-2, and hTTLL12 and Control
clones (Figure S3C; hTTLL12 red; Control green). The modal
chromosome number for HEp-2 (data not shown) and Control
clone cells was 74. hTTLL12 overexpressing cells had significantly
more cells with greater modal chromosome numbers (p = 4.84
10212). This shows that hTTLL12 overexpression increases the
number of chromosomes per cell in HEp-2, similar to HCT-116
cells [2].
Since the difference in H4K20me3 and detyrosinated tubulin
levels could have been a consequence of differences in cell cycle
distribution of the cell populations that were compared, we studied
whether there were differences when cells were at the same stage
of the cell cycle. Cells were synchronised by double thymidine
block, released, collected every 2 hours for 24 hours, analysed by
FACS for DNA content, and time points were selected at which
the cells were predominantly in the S, G2/M and G1 phases
(Figure 4A). Western blot analysis showed that there were
differences in modifications in the selected populations
(Figure 4B), suggesting that the differences are not due to
differences in cell cycle distributions of the hTTLL12 overex-
pressing and control clones. Interestingly, we observed that the
time to transit G2 and M and then enter into G1 was delayed in
the hTTLL12 overexpressing cells (Figure 4C), suggesting that
hTTLL12 could have an effect on the length of the G2 or M
phases of the cell cycle.
Figure 2. hTTLL12 changes H4K20me3 levels and co-immuno-
precipitates with HP1c, H3 and H4K20me3. A. hTTLL12
(hTTLL12_A-E) or Control (Control_A, _B, _D, _E) clones were harvested
in Laemmli buffer and subjected to SDS-PAGE and WB. Representative
WBs (upper part; hTTLL12_A and Control_E) are shown for hTTLL12
(30 mg protein/lane) or H4K20me3 and TBP (20 mg protein/lane). Similar
WBs were probed with different antibodies, quantified by densitometry
and normalized to TBP levels (lower part), to determine methylated
H4K20me3, H4K20me1, H4K20me2, H3K9me2, H3K9me3, H3K4me2,
H3K4me3 and H3K27me2 levels. Data represent average protein levels
6 SEM in hTTLL12 lysates relative to average levels in Control lysates
(n = 2 except for H4K20me3 (n = 5) and H3K9me3 (n = 3)). B. HEp-2 cells
were transfected with 10 nM control siRNAs (siLuciferase, siCtrl, siGFP or
siSilencer) or 10 nM hTTLL12-specific siRNA (sihTTLL12_2-5). 72 hours
after transfection, cells were lysed in Laemmli buffer and analysed by
SDS-PAGE and WB. Chemiluminescent signals were detected using a
Versadoc image station (hTTLL12) or film (H4K20me3). Representative
WBs (upper part) for hTTLL12 (40 mg of total protein/lane), H4K20me3
(5 mg total protein/lane) and respective TBP signals in siLuciferase,
siSilencer and sihTTLL12_2 lysates. H4K20me3 levels were quantified
using Quantity One software and normalized to TBP (lower left part).
Data represent average H4K20me3 levels 6 SEM in sihTTLL12 lysates
relative to average levels in control siRNA lysates (siControl; n = 3). *
Statistically significant difference to the levels in siControl (P,0.05,
Student’s t-test). To evaluate H3K9me3 levels (lower right part), HEp-2
cells were transfected with non-targeting control siRNA (siGFP or siCtrl)
or hTTLL12-specific siRNA (20 nM sihTTLL12_3 or 10 nM sihTTLL12_4).
48 hours after transfection, cells were harvested in Laemmli buffer and
subjected to SDS-PAGE and WB. H3K9me3 levels were quantified by
densitometry and normalized to TBP. Data represent average protein
levels 6 SEM in sihTTLL12 lysates relative to average levels in non-
targeting siRNA lysates (siControl; n = 2). C. WB showing co-immuno-
precipitation of HP1c, Histone H3 and H4K20me3 with M2-Flagged
hTTLL12 from nuclear extract of stable clone hTTLL12_A. Similar results
were obtained with two other clones (hTTLL12_B and hTTLL12_C, data
not shown). Lane 1: 1% of the input; lane 2: IP of M2-Flagged hTTLL12 in
the presence of 500 mg M2-peptide, lane 3: IP M2-Flagged hTTLL12 in
the absence of M2-peptide. * Statistically significant (P,0.05, Student’s
t-test) difference to the levels in Control or siControl.
doi:10.1371/journal.pone.0051258.g002
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Mitotic phenotypes induced by hTTLL12 up and down
regulation
Microscopy of individual living cells was used to study the effects
of altering hTTLL12 levels on the duration of different phases of
the cell cycle. Chromosomes were detected by fluorescent labelling
with Hoechst vital stain and cells by phase contrast (Figure 5A).
Ten clones (5 hTTLL12, 5 Control) and HEp-2 were plated and
after 48h the unsynchronized cultures were observed every minute
for 4 hours. hTTLL12 overexpressing cells had a longer mitotic
duration than Control clones and HEp-2 [6169 versus 4064 and
3761 minutes; Figure 5A, Figure 5B and Figure S5A]. The
increased duration of mitosis resulted from increases in both
prometaphase and metaphase [hTTLL12 versus Control clones:
prometaphase 3466 versus 2562 min (p = 0.016), metaphase
2763 min versus 1662 min (p= 1.3 1024)]. There were no
significant overall differences in other parameters (data not
shown), including: (1) chromosome ‘‘delay’’ and ‘‘lag’’ [the
presence of chromosomes that did not congress immediately to
the metaphase plate (Figure S4A), or that remained stranded at the
spindle equator after anaphase, respectively]; (2) chromatin
fragmentation and membrane blebbing (markers of cell death),
(3) variations in sharpness and centring, and reorientation of the
metaphase plate (markers for spindle positioning defects), (4)
multipolar spindles (a marker for centrosome duplication and
spindle assembly defects); and (5) ingression of the furrow during
cytokinesis (a marker for cytokinesis defects). This indicated that
the predominant effect of hTTLL12 overexpression is prolonga-
tion of prometaphase and metaphase that cumulate to increase
mitotic duration.
In parallel, hTTLL12 was depleted from HEp-2 cells with
siRNAs (6 sihTTLL12 and 3 controls, used individually;
hTTLL12 was decreased by more than 70% 72–80 hours post-
transfection). The unsynchronized cultures were observed every
3 minutes for 10 hours. hTTLL12 down regulation increased
mitotic duration to 63615 minutes, compared to 3862 minutes
for the controls (Figure 5C & Figure S4A). About 17% of the
hTTLL12 down regulated cells displayed very long mitotic
durations, of more than 90 minutes, compared to about 4% of
the control cells (Figure S4C). hTTLL12 down regulation did not
grossly alter chromosome segregation and cytokinesis compared to
the controls. These results show that down regulation as well as up
regulation of hTTLL12 had similar effects on mitotic duration. Up
and down regulation also had similar effects on the levels of
detyrosinated tubulin (see above), suggesting that cells are
exquisitely sensitive to hTTLL12 levels.
To facilitate identification of mitotic defects, we focussed on
cells with a mitotic duration longer than 50 minutes. Within the
hTTLL12 overexpressing cell population, these cells were
significantly delayed in chromosome congression to the metaphase
plate (Figure S5). They also had differences in spindle positioning
prior to anaphase (Figure S6). Control cells displayed a sharp
chromosome plate at the equator of the cell very soon after NEB,
even before completion of chromosomes congression, indicating
that they achieved spindle alignment parallel to the substrate
during prometaphase. Modifications of hTTLL12 expression
affected spindle positioning, as shown by displacement of the
chromosome plate from the cell centre, rotational reorientation of
the plate within the cell, and oscillations between a sharp and a
fuzzy plate (Figure S6B & C). These are typical characteristics of
spindles that are not stably maintained in the cell centre and that
change the spatial orientation of their axis. We deduce that
hTTLL12 has effects on the spindle that affect congression and
positioning, which could affect mitotic timing.
Figure 3. hTTLL12 alters detyrosinated tubulin levels and co-
immunoprecipitates with a-tubulin. A. hTTLL12 (hTTLL12_A-E) or
Control (Control_A, _B, _D, _E) clones were harvested in Laemmli buffer
and analysed by SDS-PAGE and WB. Representative WBs (left part) for
detyrosinated tubulin (deY-tub) and TBP (40 mg total protein/lane;
Control_D and hTTLL12_B shown). deY-tub levels from similar WBs were
quantified by densitometry and normalised to TBP (right part). Data
represent average detyrosinated tubulin levels 6 SEM in hTTLL12
lysates relative to average levels in control lysates (n = 2). * Statistically
significant difference to the controls (P,0.05, Student’s t-test). B. HEp-2
cells were transfected with 10 nM control siRNAs (siLuciferase, siCtrl,
siGFP or siSilencer), 10 nM hTTLL12-specific siRNA (sihTTLL12_1-6), or
10 nM positive control siRNA (siTTL_1-2). 72 hours after transfection,
cells were lysed in Laemmli buffer and analysed by SDS-PAGE and WB.
Chemiluminescent signals were detected using a Versadoc image
station. Representative WBs (left part) for detyrosinated tubulin (40 mg
of total protein/lane) and TBP signals (note that lanes 1–3 of the TBP
blot are identical to the ones shown in the upper left part of Figure 2B)
in siLuciferase, siSilencer, sihTTLL12_2 and siTTL_2 lysates. Detyrosi-
nated tubulin levels were quantified using Quantity One software and
normalized to TBP (right part). Data represent average detyrosinated
tubulin levels 6 SEM in sihTTLL12 and siTTL lysates relative to average
levels in control siRNA lysates (siControl; n = 5). * Statistically significant
difference to the levels in siControl (P,0.05, Student’s t-test). C.
Representative WB showing the co-immunoprecipitation of a-tubulin
with Flag-hTTLL12 immunoprecipitated from the stable clone
hTTLL12_A (lane 3). Similar results were obtained with 4 other clones
(hTTLL12_B-E, data not shown). Parental HEp-2 cells (lane1) and a stable
HEp2-clone overexpressing Flag-NudCD2 (lane 2) were used as negative
controls. IgG HC: IgG heavy chain.
doi:10.1371/journal.pone.0051258.g003
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hTTLL12 lacks HMTase activity in vitro
The presence of a SET-like domain and the effects of hTTLL12
on the levels of H4K20me3 raised the possibility that hTTLL12
could have HMTase activity. In order to investigate this
possibility, we used in vitro HMT assays in which the transfer of
radiolabelled methyl groups from SAM to purified histones is
followed by fluorography. The positive control was NSD1, which
has HMTase activity towards both H4K20 and H3K36 [32]. We
expressed hTTLL12 in bacteria using the Glutathione S-transfer-
ase (GST) Gene Fusion system and in mammalian BHK21 cells
using Vaccinia virus Ankara strain (MVA) vectors [33] or
establishing stable clones of HEp-2 cells that express Flag-tagged
hTTLL12. Tagged proteins were purified by affinity chromatog-
raphy. The bacterial proteins were essentially pure, whereas the
mammalian proteins contained substantial levels of EEF1A1.
EEF1A1 was identified by mass spectrometry and WB in both
mammalian expression systems, and was shown to co-immuno-
precipitate with hTTLL12 (see Figure S1). As expected, we found
that a fragment of NSD1 that contains the SET domain [GST-
NSD1 (1700–1987)] catalyses the methylation of core histones
[Figure 6A; compare lanes 2 & 3 containing different amounts of
GST-NSD1 (1700–1987) with lane 1 lacking histones]. In
comparison, GST-hTTLL12 (50–250), which contains the SET
domain of hTTLL12 and which was purified in parallel with
GST-NSD1 (1700–1987), did not have detectable HMTase
activity (Figure 6A, lanes 4–6). The same results were obtained
in several independent experiments in which the NSD1 and
hTTLL12 recombinants were purified in parallel. Similar lack of
activity was observed with full length hTTLL12 purified from
vaccinia virus infected cells, whether or not the hTTLL12 fraction
contained EEF1A1 (Figure 6A, lanes 7–10 and 12). TTL,
expressed and purified using the same system, also lacked
HMTase activity, as expected from the lack of a SET domain
(lane 11). However, this protein was enzymatically active in
tubulin tyrosine ligase assays [[33] and see below]. This suggests
that the experimental procedure used is compatible with the
isolation of enzymatically active proteins. We also purified
hTTLL12 from the clones in which endogenous H4K20me3
levels were altered due to hTTLL12 overexpression. Flag-tagged
hTTLL12 was purified from fractionated cell extracts from two
overexpressing clones (hTTLL12_C & hTTLL12_D). Control
clones (Control_C, Control_D) were processed in parallel to give
control extracts. We used fractionated cells since hTTLL12 is
located in the cytoplasm and the nucleus of cells, in different
proportions depending on the cell type [2]. Three fractions were
prepared, the cytoplasmic fraction, a nuclear 0.4 M NaCl wash,
and a subsequent 1 M salt wash. The relative levels of hTTLL12
in the three fractions were approximately 100:2:0.4 in HEp-2.
Purified hTTLL12 did not have any additional HMTase activity
compared to the control extracts [Figure 6B, lower panel; compare
lanes 4, 5 with 3, lanes 8, 9 with 7, and see the lack of detectable
incorporation in lane 11; see also the signal for the positive control
GST-NSD1 (1700–1987)]. There was background incorporation
of radioactivity that was histone dependent (compare lanes 2 and
Figure 4. Cell cycle phase dependence of the levels of detyrosinated tubulin (deY-tub) and H4K20me3 in clones overexpressing
hTTLL12 compared to control clones. A. FACS scans of cells released from a double thymidine block at the indicated times. The times shown are
those at which the cells were predominantly in S, G2/M and G1, except for the 18 hour time point. One representative synchronisation is shown. B.
WBs, from one experiment, of whole cell lysates from cells synchronised in the G1, S and G2/M phases, respectively. The graphs are the averages from
3 independent experiments. * p,0.05. C. Proportion of cells in G1 at different times after release from double thymidine block. The average from 3
different experiments (up to 18 h) is shown. c2, c4 =DNA complements as measured by propidium iodide.
doi:10.1371/journal.pone.0051258.g004
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3, 4 and 5, and 9 and 10). In some cases the background activity
appeared to be lower in the hTTLL12 containing extracts,
suggesting that the hTTLL12 extracts could contain inhibitors.
However, adding hTTLL12 extracts to either GST-NSD1 (1700–
1987)] or control extracts did not significantly decrease their
activities (data not shown). The results were reproducible, using
independent protein preparations (data not shown). Taken
together, our results suggest that hTTLL12 does not have
HMTase activity.
hTTLL12 lacks TTL activity in vitro
Since hTTLL12 has a TTL-like domain, we studied whether it
has TTL activity. We used in vitro assays with [14C] labelled
tyrosine, purified tubulin, and either extracts from transiently
transfected cells or proteins purified from mammalian cells
infected with appropriate viral expression vectors. Extracts from
cells transfected with the TTL expression vector exhibited
increased TTL activity compared to mock-transfected cell extracts
(Figure 7A, lanes 9 and 4, respectively). The reactions were
specific, as shown by dependence on cell extract (1), ATP (lane 2),
Figure 5. hTTLL12 up and down regulation prolong mitotic duration of HEp-2 cells. A. Example frames from live cell movies of a HEp-2 cell
stained with vital Hoechst. The time between nuclear envelope breakdown (NEB, first arrowhead, 0 min) and anaphase onset (second arrowhead) are
indicated. Upper panel: fluorescent images (Hoechst), middle panel: phase contrast images, lower panel: overlay. B–C. Cumulative frequency (plot,
right axis) and frequency distribution (histogram, left axis) of mitotic duration for hTTLL12 clones (B) and siRNA transfected HEp-2 (C). B. hTTLL12
(hTTLL12_A-E) or Control (Control_A-E) clones were seeded in 6-well plates. 48 hours post seeding, cells were treated with vital Hoechst and analysed
(Experimental Procedures). Parental HEp-2 cells (light green), and the averages of the hTTLL12 (red) and Control (dark green) clones are plotted. C.
HEp-2 cells were transfected separately with 12.5 nM sihTTLL12_1-6 or controls (siLuciferase, siCtrl, siScramble). 72 hours post transfection, cells were
stained with vital Hoechst and analysed. HEp-2 cells; light green; averages of sihTTLL12s; red; averages of siControls; dark green. More detailed
information and statistical analysis can be found in Figure S1.
doi:10.1371/journal.pone.0051258.g005
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tubulin (lane 3) and the use of an expression vector with the
appropriate orientation (lane 8). Extracts from cells transfected
with expression vectors for hTTLL12 (6) and Flag-hTTLL12 (7)
did not increase endogenous TTL activity. As might be expected,
transfection of the hTTLL12 anti-sense construct did not affect
TTL activity. hTTLL12 and TTL were efficiently expressed in
these experiments (Figure 7B), showing that lack of activity was not
due to absence of expression. We also tested the activity of TTL
and hTTLL12 purified from mammalian BHK21 cells infected
with appropriate Vaccinia virus Ankara strain (MVA) vectors [33].
As expected, TTL catalysed ligation of labelled tyrosine to tubulin
in a dose dependent manner (Figure 7C). In contrast, equivalent
amounts of hTTLL12 or hTTLL12 complexed to EF1A1 did not
exhibit any activity relative to control reactions lacking purified
proteins (the first bar). Adding hTTLL12 or hTTLL12 +EEF1A1
to TTL did not affect its activity, showing that these preparations
did not contain contaminants that may have inhibited the
reactions. Overall, these results suggest that hTTLL12 is devoid
of TTL activity.
Discussion
hTTLL12 is the most divergent member of the 14-gene TTL
family in humans. It has a phylogenetically conserved association
of two domains (SET- and TTL- like) that predict that it could be
involved in histone and tubulin modification. We found that
changes in hTTLL12 expression affect histone and tubulin
modifications in cells. They also affect mitotic duration, which
could be linked to both types of modification. However hTTLL12
appears to lack these histone and tubulin modification activities in
vitro. These results suggest that hTTLL12 is an inactive enzyme
homologue that may have a regulatory function.
TTLL12 is an unusual member of the TTL family, according to
bioinformatics analysis. TTLL12 has a unique phylogenic
distribution and it has features that distinguish it from the other
family members in humans. For example, it is the only member of
the TTLL family to be identified in plant genomes, such as
Arapidopsis thaliana [34]. The TTL domain of hTTLL12 lacks
three of the seven motifs that are conserved in the other family
members. Furthermore, it has several residues that are specific to
hTTLL12 and conserved orthologues in different species. The N-
terminal region of hTTLL12 has homology to SET domains in a
number of human proteins. The overall sequence similarity is low,
which is a general characteristic of SET domains [for reviews see
[5,6,7,24]]. The TTLL12 SET domain has also been detected by
Aravind et al [3], who studied the natural history of the eukaryotic
chromatin protein modification system. They propose that the
TTLL12 clade is one of at least 5 types of SET domains that were
present in the LECA (last eukaryotic common ancestor). TTLL12
is one of the major lineages of SET domains that might have
played the initial role in the establishment of multiple distinct
heterochromatic and euchromatic states that are likely to have
been present throughout much of eukaryotic evolution.
The presence of a SET-like domain in hTTLL12 prompted us
to investigate its role in histone lysine methylation. We found that
hTTLL12 is functionally linked to at least one histone methyla-
tion. Altering hTTLL12 levels affects H4K20me3 levels, without
influencing other methylation states of H4K20 (me2 and me1) and
methylation of H3K4 and H3K9. However, we did not detect
histone methyl transferase activity in vitro with hTTLL12 proteins
purified from various sources. hTTLL12 interacts with EEF1A1,
raising the possibility that hTTLL12 may methylate this protein.
EEF1A1 has been shown to be methylated and two histone
methyltranferases that mediate this modification have been
identified in Saccharomyces cerevisiae [35]. However, we did
not detect methylation of EEF1A1 by hTTLL12 in our in-vitro
methylation experiments. We propose that hTTLL12 affects
H4K20 trimethylation in cells by an indirect mechanism, perhaps
by altering the expression and/or interactions with factors
implicated in this modification. hTTLL12’s SET-like domain
appears to lack a critical asparagine residue that is important for
Figure 6. hTTLL12 lacks HMTase activity. The assays included
histones purified from calf thymus (A, lanes 2, 3,5, 6, 8–11; B lanes 1, 3,
5–9, 11) as substrate and proteins to be tested for HMT activity that
were purified from bacterial, viral and mammalian cell expression
systems. The upper panels in each part (A & B) are Coomassie Blue
stained SDS-polyacrylamide gels of the expressed proteins and the
lower panels are the corresponding fluorograms centred on the core
histones (Histones). The proteins tested for HMTase activity were
expressed and purified from appropriate pGEX vector transformed E.
coli [GST-NSD1 (1700–1987) (G-NSD1), GST-TTLL12 (50–250) (G-TTLL12)],
recombinant vaccinia virus Ankara strain (MVA) infected mammalian
cells [vTTLL12, vTTLL12 and vTTLL12 + E (a fraction that contains
EEF1A1)] and HEp-2 cell clones transformed with pSG5-puro-Flag (CON-
D) or pSG5-puro-Flag TTLL12 (L12-C & L-12-D). The HEp-2 proteins were
purified from cytoplasmic (c-CON-D, c-L12-c, c-L12-D), nuclear (n-CON-
D, n-L12-C, n-L12-D) and 1M KCl (1M-L12-C) fractions. 10 ml reactions
were loaded on 15% SDS-PAGE gels. In A, the approximate amounts of
protein used per reaction were: GST-NSD1 (1700–1987) (1 mg, lanes 1, 2;
0.5 mg, lane 3), GST-TTLL12 (50–250) (0.5 mg, lanes 4, 5; 0.25 mg, lane 6),
TTLL12 (3 mg, lanes 7, 8; 1.5 mg lane 9), TTLL12 + EEF1A1 (2 mg, lanes 10,
12) and TTL (4 mg, lane 11). In B, they were GST-NSD1 (1700–1987)
(2 mg, lanes 1, 12), TTLL12 (0.25 mg, lanes 4–6; 0.005 mg lanes 8–10,
0.001 mg lane 11). TTLL12 was not detected in the equivalent fractions
purified from the control HEp-2 clone (CON-D). In B, lanes 2–11, the
band migrating slightly faster than GST-NSD1 (1700–1987)) is IgH from
the affinity column that is eluted under the harsh denaturing conditions
used for sample preparation for SDS-PAGE.
doi:10.1371/journal.pone.0051258.g006
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methyltransferase activity. A single asparagine to glutamine
mutation in the SET domain of Neurospora DIM-5 strongly reduces
the enzyme activity and binding to the cofactor SAM [S-Adenosyl-
L-methionine, N241Q, [36]]. The predicted corresponding
position in hTTLL12 (position 458; Alignment S2) is in fact a
glutamine residue. hTTLL12 alters the expression levels of
proteins that have indirect effects on trimethylation of H4K20
[Rb, HP1a; [26,27,37]]. TTLL12 has been shown to interact with
SAP25 [38] and Arid1A [39], which are involved in nucleosome
remodelling. It remains to be seen whether these interactions
account for its effects on histone modification.
hTTLL12 is also functionally linked to tubulin tyrosination [this
report and [2]]. This effect appears to be indirect, for a number of
reasons. Increasing and decreasing hTTLL12 levels increase the
levels of detyrosinated tubulin, which would be difficult to explain
by a direct effect. In our experiments, hTTLL12 purified from a
number of sources does not have tubulin tyrosine ligase activity. In
other studies it was shown to lack polyglutamylation [23] and
polyglycylation [40] activities. Lack of activity is also suggested by
its sequence. In the alignment of TTL domains (Alignment S1)
hTTLL12 seems to lack residues that are important for ATP/
Mg2+ binding [GXGIRSLDT426–429 and FEyyGFDRRA-
MYAVD578–584[41,42,43]]. The GXGI ATP/Mg2+ binding motif
in hTTL is important for TTL activity, since this activity is
abolished by mutation of the corresponding 157GEGI160 in the
human TTL protein to 157GAAA160 (our unpublished data).
Overall, our results suggest that hTTLL12 has indirect and
perhaps regulatory roles in histone modification and tubulin
detyrosination, rather than direct enzymatic activity.
Altered tubulin tyrosination and H4K20 methylation is
compatible with the phenotypic effects of hTTLL12. hTTLL12
up- and down-regulation prolong mitotic duration. There are also
more subtle defects in chromosome congression and positioning, in
cells with the longest mitotic durations. Detyrosinated tubulin is
enriched in the mitotic spindle, but less so in astral microtubules of
the spindle [44]. Detyrosination could be an essential regulator of
chromosome segregation, since the tyrosination state of a-tubulin
regulates the activity of the depolymerizing kinesin MCAK [45],
which is essential for proper chromosome segregation in anaphase
[46]. H4K20 mono-methylation has been implicated in mitosis,
but the link with tri-methylation is weaker [reviews:
[47,48,49,50]]. There are high levels of H4K20me3 in centro-
meric heterochromatin, which is required for the proper
segregation of chromosomes during mitosis [51,52]. hTTLL12
affects HP1a levels. HP1 proteins are required for correct
chromosome segregation in Drosophila embryos [53], and during
Figure 7. hTTLL12 lacks tubulin tyrosine ligase activity, as shown with tubulin tyrosine ligase (TTL) assays using cell extracts (A, B)
or purified proteins (C). (A) TTL assays on extracts of transfected HEp-2 cells. Control reactions lacked cell extract (1), ATP (2) or purified tubulin (3).
Test reactions contained extracts from cells transfected with: no DNA (4, mock), pc-AS 153 (5, antisense hTTLL12), pcDNA3-hTTLL12 (6), pSG5-puro-
hFlag TTLL12 (7, Flag-hTTLL12), pc-AS TTL (8, antisense hTTL), and pcDNA3-TTL (9). (B) Expression of TTLL12 and TTL in transfected cell extracts. WBs
were used to detect hTTLL12, TTL and TBP (loading control) in the extracts used for the activity tests. (C). TTL activity of purified proteins. The in-vitro
reactions contained the indicated quantities (mg) of TTL, hTTLL12 and hTTLL12 complexed to EEF1A1 that had been purified from mammalian cells
infected with corresponding recombinant Ankara strain (MVA) vaccinia viruses. The counts were normalised to 100 for 10 mg TTL. Error bars indicate
standard deviations.
doi:10.1371/journal.pone.0051258.g007
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metaphase only HP1a, and not HP1b and HP1c, co-localises with
centromeric heterochromatin [54].
A role for hTTLL12 in mitosis is also supported by the
MitoCheck consortium [55,56]. They systematically analyzed
genes and proteins that are required for chromosome segregation
and cell division in human cells. 22,000 human genes were
inactivated individually by RNA interference (RNAi) in cultured
human cells. Cellular phenotypes were recorded by high-
throughput live cell imaging. Automated analyses of images and
movies revealed that about 600 out of the 22,000 genes play a role
in mitosis. One of these genes is hTTLL12. The phenotypes
observed were dynamic changes, segregation problems, strange
nuclear shapes, nuclei that stay together and apoptosis. Different
aspects of this phenotype were observed with 2 out of 4 dsRNAs
used to down regulate hTTLL12 (http://www.mitocheck.org/cgi-
bin/mtc?query = ttll12&query_type = genes). These phenotypes
are compatible with our observations. Significantly, these
phenotypes were not observed with any of the other members of
the TTL family. hTTL and hTTLL1 were found to have effects
on secretion, and hTTLL4 on apoptosis.
We found that hTTLL12 induces changes in DNA content and
chromosome numbers by FACS and karyotype analysis, respec-
tively. The changes in chromosome number are observed in some
cells in each clone, which are composed of a mixed population of
cells with different chromosome numbers. This suggests that
hTTLL12 overexpression favours relatively rare events that are
not completely eliminated by cell death. A strong effect on
chromosome number would be expected to be lethal to the cell.
hTTLL12 appears to predispose cells to low frequency events that
may accumulate with time, and perhaps help cells adapt during
tumour progression. hTTLL12 has been linked to altered
chromosome numbers by others. In a study of amniotic fluid
from fetuses with the two most common human autosomal
aneuploidies, trisomies 21 and 18, in which RNA expression was
compared to euploid fetuses matched for sex and gestational age,
one of the four RNAs that was upregulated in both comparisons
was hTTLL12. hTTLL12 does not map to the chromosomes with
altered copy number, suggesting that copy number did not
account for the differences [57,58]. It remains to be seen whether
there is any connection between these studies and our observa-
tions.
Our working hypothesis is that hTTLL12 could be a pseudo-
enzyme that regulates histone and tubulin modifications and
thereby microtubule dynamics, mitosis and chromosome number
instability. hTTLL12 may exploit its ability to bind the same
substrates and cofactors as other TTLs and SET domain factors.
Consequently, hTTLL12 would be well placed to directly or
indirectly regulate the biological processes in which its cognate
enzymes act. Such enzymes could include the many tubulin-
modifying and -demodifying enzymes that have been recently
characterised and shown to regulate microtubule functions
through different modifications. Combinatorial use of tubulin
modifications could generate a dynamic microtubule code [10,12].
hTTLL12 would thus resemble the numerous other inactive
enzyme homologues that contain conserved substitutions in their
catalytic sites and have regulatory roles [59]. Most enzyme families
have inactive homologues (pseudo-enzymes) that are well
conserved. They appear to have sufficient functional importance
to resist selective pressure during evolution. hTTLL12 may be
another example of a dead enzyme with an important physiolog-
ical role. It is possible that the study of hTTLL12 could offer novel
insights into biochemical pathways controlled by its active
counterparts.
Supporting Information
Supporting Experimental Procedures S1.
(PDF)
Figure S1 KIAA0153 might be part of a complex
containing EF1A1, a- and b-tubulin. A Purification of flag-
hTTLL12 by affinity and further Coomassie staining revealed an
extra band identified as EF1A1 by Mass Spectrometry. 1: total cell
extract, 2: column flow through, 3: column wash, 4: proteins
eluted by peptide competition. B Silver stained gels and bands
identified by Mass Spectrometry. 1: marker, 2 and 3: proteins
eluted from columns loaded with cell extract from vector stable
transfectant (2), and sense stable transfectant. Major proteins
identified are indicated. The other bands correspond to heat shock
proteins and degradation products from either hTTLL12 or
EF1A1 (not indicated). 75, 50, 37 correspond to molecular weight
markers (61023 kD).
(PDF)
Figure S2 hTTLL12 localises to mitotic spindle micro-
tubules and centrosomes. HEp-2 cells were fixed and co-
stained with hTTLL12 (2065, red) and b-tubulin (green) (panel A),
hTTLL12 (2089, red) and b-tubulin (green) (panel B) or hTTLL12
(2089, red) and c-tubulin (green) (panel C) specific antibodies.
Images were taken by confocal microscopy.
(PDF)
Figure S3 hTTLL12 expression deregulation in HEp-2
cells alters growth and DNA-profiles. A. Growth of Control
(Control_A-E) and hTTLL12 (hTTLL12_A-E) clones was mea-
sured by MTT in quadruplicate during ten days. Data represent
average values 6 average deviation of Control (black) and
hTTLL12 (white) clones. * Statistically significant difference to
Control cells (P,0.05, Student’s t-test). B. hTTLL12
(hTTLL12_A-E) or Control (Control_A, _B, _D, _E) clones were
seeded, harvested in Laemmli buffer and subjected to SDS-PAGE
and WB (20 mg protein/lane). Histone H4 (H4), Rb, HP1a, HP1b
and HP1gamma levels were quantified by densitometry and
normalized to TBP. Data represent average protein levels 6 SEM
in hTTLL12 lysates relative to average levels in Control lysates
(n = 3 for Rb, HP1b, HP1gamma, n= 4 for H4, HP1a). C. The
DNA profile of controls (HEp-2, Control_A, _B, _F, and _G;
purple bars) and hTTLL12 clones (hTTLL12_A-E; red bars) was
analyzed by FACs after propidium iodide staining. 2c, 4c and 8c:
diploid, tetraploid and octaploid DNA contents. D. Chromosome
numbers per cell. For each clone (Control_A-E: ‘‘triangle’’ A,
‘‘dot’’ B, ‘‘cross’’ C, ‘‘square’’ D, ‘‘diamond’’ E, green;
hTTLL12_A-E: ‘‘dot’’ A, ‘‘cross’’ B, ‘‘square’’ C, ‘‘diamond’’ D,
‘‘triangle’’ E, red), sixty-five metaphase spreads (1–65, y axis) were
stained with Giemsa and the number of chromosomes per mitosis
was counted (X-axis). The modal chromosome number of HEp-2
cells is 74. * Statistically significant difference between the average
chromosome numbers in hTTLL12 and Control clones (P,0.05,
Student’s t-test).
(PDF)
Figure S4 Altering hTTLL12 expression prolongs mitot-
ic duration (see Fig. 5).Mitotic duration was scored from time-
lapse movies (Experimental Procedures). The total numbers of
clone or transfected cells analysed were: 205 HEp-2, 263
Control_A-E, 372 hTTLL12_A-E, 591 control siRNAs (siCtrl,
siLuciferase, siScramble, used separately and combined), and 899
sihTTLL12_1-6, used separately). A. Data represent average
mitotic duration 6 STDEV (standard deviation) for HEp-2,
hTTLL12 and Control clones, and control siRNAs (siControl) and
sihTTLL12 transfected cells. * Statistically significant difference
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between hTTLL12 clones and Control clones or Hep-2, as well as
between sihTTLL12 and siControl or HEp-2 (P,0.05, Student’s
t-test). B. Average percentages for each clone type (HEp-2,
Control_A-E and hTTLL12_A-E) 6 STDEV divided into time
intervals. * Statistically significant difference between hTTLL12
clones and Control clones or HEp-2 (P,0.05, Student’s t-test). C.
Average percentages for each siRNA type (non-transfected (HEp-
2), siControl (siCtrl, siLuciferase, siScramble) and siTTLL12
(sihTTLL12_1-6)) 6 STDEV divided into time intervals.
* Statistically significant difference between sihTTLL12 transfect-
ed cells and siControl or HEp-2 (P,0.05, Student’s t-test).
(PDF)
Figure S5 hTTLL12 overexpression leads to chromo-
some congression delay in HEp-2 cells. The total numbers
of cells analysed by time lapse movies (Experimental Procedures)
were 420 for Control_A-E and 491 for hTTLL12_A, _B, _D, and
_E. A. Representative fluorescent (Hoechst) images of metaphases
of a HEp-2 cell (Control), and a hTTLL12 overexpressing cell
showing congression delay. Red arrows mark chromosomes that
are delayed. 0 min is the time of NEB. B. Average percentages for
each clone type 6 STDEV having congression delay divided in
time intervals (mitotic duration#50 min or.50 min) scored from
time lapse movies of hTTLL12 and Control clones. * Statistically
significant difference between Control and hTTLL12 clones
(P,0.05, Student’s t-test).
(PDF)
Figure S6 hTTLL12 up and down regulation leads to a
spindle positioning phenotype in HEp-2 cells. The
orientation and placement of mitotic spindles was scored from
time-lapse movies (Experimental Procedures). The numbers of
cells analysed were: 262 HEp-2, 420 Control_A-E, 380
hTTLL12_A, _B, _D clones, 502 control siRNAs (siCtrl,
siLuciferase, siScramble, used separately and combined), and
973 sihTTLL12 (sihTTLL12_1-6, used separately). A. Phase
contrast and fluorescent (Hoechst) image overlays of metaphases
from representative cells: a HEp-2 (Control, upper panel), a
hTTLL12 clone (hTTLL12, middle panel) and a sihTTLL12
transfected cell (sihTTLL12, lower panel). Red lines and grey
circles highlight metaphase plate position with respect to the
circumference of the cell. 0 min is the time of anaphase onset. B.
Average percentages for each cell type 6 STDEV with the spindle
positioning phenotype divided into time intervals (mitotic duration
#50 min or .50 min) for HEp-2 cells, hTTLL12 and Control
clones. * Statistically significant (P,0.05, Student’s t-test) differ-
ence between hTTLL12 clones and Control clones or HEp-2 cells.
C. Average percentage for each clone or cell type 6 STDEV with
the spindle positioning phenotype divided into time intervals
(mitotic duration #50 min or .50 min) scored from time lapse
movies with HEp-2 or cell transfected with control siRNAs or
sihTTLL12s. * Statistically significant difference between
sihTTLL12 and control siRNA transfected cells or HEp-2
(P,0.05, Student’s t-test).
(PDF)
Table S1 Amino acid conservation in the TTL core
domain of TTL family members. The consensus sequence
for the human family and the corresponding sequence in
hTTLL12 are from Alignment S1. The alignment for different
species is not shown.
(PDF)
Table S2 The sequences and their positions in hTTLL12
that are highly conserved in other human SET domains
(see Alignment S2) are listed. Letters are coloured according
to Fig. 1 in Qian et al. (38): red: absolutely conserved; blue: very
highly conserved; black: highly conserved). The corresponding
conserved structural elements are indicated (38). Amino acids 158–
188 are the approximate limit of a predicted insert in the SET
domain that is deduced from Alignment S2. Sequence alignments
of hTTLL12 with several plant and unicellular ciliate protozoan
orthologues (e.g. NP_177879.3, Arabidopsis thaliana;
XP_002326123 Populus trichocarpa; ABF94289, Oryza sativa;
XP_001020206, Tetrahymena thermophila SB210; XP_001454840,
Paramecium tetraurelia strain d4-2; XP_001580810, Trichomonas
vaginalis G3) indicate that these orthologues have an insert that
has an additional sequence inserted in this position (data not
shown).
(PDF)
Table S3 The 55 kDa co-immunoprecipitated protein
band (Fig. 3C) corresponds to a-tubulin. The table
summarizes tryptic peptide sequences, their relative positions on
the a-tubulin primary protein sequence, their measured masses
and computed masses. * oxidized methionine.
(PDF)
Alignment S1 Multiple sequence alignment of the TTL
domains of the human TTL protein family members.
(PDF)
Alignment S2 Multiple sequence alignment of the
hTTLL12 SET-like domain and the SET domains of
human proteins.
(PDF)
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